pipemidic acid has been researched along with caffeine in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (50.00) | 18.7374 |
| 1990's | 2 (33.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Barnett, G; Carbó, M; de la Torre, R; Segura, J | 1 |
| Harder, S; Papenburg, A; Staib, AH; Stille, W | 1 |
| Beer, C; Harder, S; Papenburg, A; Shah, PM; Staib, AH; Stille, W | 1 |
| Badenas, JM; Camí, J; Carbó, M; De la Torre, R; Segura, J | 1 |
| Battula, N; Doehmer, J; Flick, I; Fuhr, U; Keita, Y; Kudla, C; Staib, AH; Wölfel, C | 1 |
2 trial(s) available for pipemidic acid and caffeine
| Article | Year |
|---|---|
4-quinolones inhibit biotransformation of caffeine.
Topics: Adult; Biotransformation; Caffeine; Ciprofloxacin; Dose-Response Relationship, Drug; Drug Interactions; Enoxacin; Humans; Male; Molecular Structure; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones; Random Allocation; Theophylline | 1988 |
Effect of quinolones on caffeine disposition.
Topics: Adult; Anti-Infective Agents; Caffeine; Drug Interactions; Humans; Male; Norfloxacin; Pipemidic Acid; Random Allocation | 1989 |
4 other study(ies) available for pipemidic acid and caffeine
| Article | Year |
|---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Pharmacokinetic determination of relative potency of quinolone inhibition of caffeine disposition.
Topics: Caffeine; Ciprofloxacin; Drug Interactions; Enoxacin; Humans; Male; Models, Biological; Norfloxacin; Ofloxacin; Pipemidic Acid; Quinolones | 1990 |
[Gyrase inhibitors modify metabolising processes in the liver].
Topics: Caffeine; Ciprofloxacin; DNA Topoisomerases, Type II; Enoxacin; Humans; Liver; Male; Naphthyridines; Norfloxacin; Ofloxacin; Oxazines; Pipemidic Acid; Topoisomerase II Inhibitors | 1987 |
Biotransformation of methylxanthines in mammalian cell lines genetically engineered for expression of single cytochrome P450 isoforms. Allocation of metabolic pathways to isoforms and inhibitory effects of quinolones.
Topics: Animals; Biotransformation; Caffeine; Cell Line; Chromatography, High Pressure Liquid; Cricetinae; Cricetulus; Cytochrome P-450 Enzyme System; Humans; Isoenzymes; Pefloxacin; Pipemidic Acid; Quinolines; Rats | 1993 |